Journal of Cognitive Psychotherapy: An International Quarterly
Volume26,Number4•2012
348 ©2012SpringerPublishingCompany
http://dx.doi.org/10.1891/0889-8391.26.4.348
Co-Occurring Disorders in the
Treatment of Nonsuicidal Self-Injury:
An Evidence-Informed Approach
Jason J. Washburn, PhD, ABPP
Alexian Brothers Behavioral Health Hospital
NorthwesternUniversityFeinbergSchoolofMedicine,HoffmanEstates,Illinois
Michelle Gebhardt, PsyD
Denise M. Styer, PsyD
AlexianBrothersBehavioralHealthHospital,HoffmanEstates,Illinois
K. R. Juzwin, PsyD
Alexian Brothers Behavioral Health Hospital
ArgosyUniversity,Schaumburg,Illinois
Lev Gottlieb, MS
NorthwesternUniversityFeinbergSchoolofMedicine,Chicago,Illinois
Co-occurring disorders are common among patients who present for treatment with nonsuicidal
self-injury (NSSI). Evidence-based approaches specifically designed for the treatment of NSSI are
limited, although interest in this area of research is growing. An evidence-informed model for the
treatment of NSSI and co-occurring disorders is presented here to stimulate interest in address-
ing co-occurring disorders in the treatment of NSSI. Case examples are presented to highlight the
complexity of treating NSSI and co-occurring disorders and to illustrate a model of treatment
at the acute level of care. The case examples also underscore the need for clinical researchers to
address co-occurring disorders when developing treatments specifically for NSSI.
Keywords: nonsuicidal self-injury; co-occurring disorders; treatment; self-regulation
N
onsuicidal self-injury (NSSI) is the deliberate, self-inflicted damage of body tissue that
induces bleeding, bruising, or pain but is absent of evidence for suicidal intent (Nock &
Favazza, 2009). NSSI does not include activities engaged in solely for socially sanctioned
purposes (e.g., body art) or common or trivial behaviors (e.g., nail-biting). Although estimates of
the lifetime prevalence of NSSI vary by study, most studies report a rate of 13% to 23% for ado-
lescents and young adults in the community and between 2% and 8% for adults and older adults
(Jacobson & Gould, 2007; Rodham & Hawton, 2009). The prevalence rate of NSSI among clinical
populations is even more varied, with rates reported between 12% and 82% (Heath, Schuab, &
Nixon, 2009; Klonsky & Muehlenkamp, 2007).